vimarsana.com

Latest Breaking News On - Hepatobiliary cancers - Page 1 : vimarsana.com

Taiho Oncology Announces Publication in The New England Journal of Medicine of Pivotal Data for Futibatinib in Previously Treated Patients With Metastatic Intrahepatic Cholangiocarcinoma

/PRNewswire/ Taiho Oncology, Inc. today announced the publication of results from the pivotal Phase 2 FOENIX -CCA2 clinical trial of futibatinib in the.

New jerseyUnited statesLipika goyalIntrahepatic cholangiocarcinomaJudy kay mooreTaiho pharmaceutical co ltdStanford school of medicineCancer centerDrug administrationTaiho oncology incOtsuka holdings co ltdEuropean society for medical oncologyNational comprehensive cancer networkTaiho oncologyNew england journalMass general cancer center

Taiho Oncology Announces Publication in The New England Journal of Medicine of Pivotal Data for Futibatinib in Previously Treated Patients With Metastatic Intrahepatic Cholangiocarcinoma

/PRNewswire/ Taiho Oncology, Inc. today announced the publication of results from the pivotal Phase 2 FOENIX -CCA2 clinical trial of futibatinib in the.

New jerseyUnited statesLipika goyalIntrahepatic cholangiocarcinomaJudy kay mooreTaiho pharmaceutical co ltdStanford school of medicineCancer centerDrug administrationTaiho oncology incOtsuka holdings co ltdEuropean society for medical oncologyNational comprehensive cancer networkTaiho oncologyNew england journalMass general cancer center

I-Mab Strengthens Management Team Designed to Accelerate Global Pipeline Development and Transformation Towards Commercialization

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesHong kongSan diegoEmilie wuAndrew zhuGigi fengJingwu zangEli lillyWeimin tangJielun zhuYifei zhuWei fuJoan shenJohn longPrnewswire the company nasdaqJiahui international cancer center

I-Mab Strengthens Management Team Designed to Accelerate Global Pipeline Development and Transformation Towards Commercialization

- New appointments as part of the Company s strategic development plans to accelerate transformation towards commercialization - Dr. Andrew Zhu, an.

United statesHong kongSan diegoEmilie wuAndrew zhuGigi fengJingwu zangEli lillyWeimin tangJielun zhuYifei zhuWei fuJoan shenJohn longCompany nasdaqCommercialization executive council

vimarsana © 2020. All Rights Reserved.